This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Bijan Alexandre Etemad-Gilbertson
Introduction
Bijan Alexandre Etemad-Gilbertson is an accomplished inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Etemad-Gilbertson holds a patent for "Anti-Betacellulin Antibodies, Fragments Thereof, and Multi-Specific Binding Molecules." This patent represents a notable advancement in the understanding and treatment of various medical conditions. With 1 patent to his name, he continues to push the boundaries of scientific research.
Career Highlights
Etemad-Gilbertson is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development initiatives. His expertise and innovative thinking have positioned him as a valuable asset within the organization.
Collaborations
Throughout his career, Etemad-Gilbertson has worked alongside talented colleagues, including Chad Eric Bigelow and Ana Maria Carrion. These collaborations have fostered a dynamic environment for innovation and have led to the development of impactful solutions in the field of biotechnology.
Conclusion
Bijan Alexandre Etemad-Gilbertson exemplifies the spirit of innovation in the biotechnology sector. His contributions, particularly through his patent and work at Novartis AG, highlight his dedication to advancing medical science. His ongoing efforts will undoubtedly continue to influence the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
